Understanding and Predicting Breast Cancer Events After Treatment (UPBEAT)

Recruiting
18 years - 100 years
Female
1 Location

Brief description of study

This study is being done to see if patients receiving chemotherapy for breast cancer affects the heart, the ability to exercise and fatigue when compared to patients who do not have cancer.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Healthy,Breast Cancer
  • Age: 18 years - 100 years
  • Gender: Female

Inclusion Criteria

Inclusion Criteria for Women with Stage I - III Breast Cancer: 

-Stage I-III female breast cancer (including inflammatory and newly diagnosed or locally recurrent breast cancer) but not metastatic breast cancer being treated with curative intent

-Scheduled to receive chemotherapy

- Able to hold breath for 10 seconds

- Able to walk at least 2 blocks without chest pain, dyspnea, shortness of breath or fainting

- Able to exercise on a treadmill or stationary cycle

- Participants in other ongoing clinical trials are eligible for this study

Inclusion Criteria for Women Free of Cancer for Comparison:

- Healthy female without known coronary artery disease

- Able to hold breath 10 seconds

- Able to walk at least 2 blocks without chest pain, dyspnea, shortness of breath or fainting

- Able to exercise on a treadmill or stationary cycle

- No hx. of cancer

- Never received chemotherapy, radiation therapy, immunotherapy, or had breast surgery

Exclusion Criteria

Exclusion Criteria for Women with Stage I-III Breast Cancer:

- Those with ferromagnetic cerebral aneurysm clips or other intracranial metal; pacemakers, defibrillators, functioning neurostimulator devices or other implanted non-compatible MRI devices

- Symptomatic claustrophobia

- At the beginning of the study, pregnant women and women who are breast-feeding will not be enrolled.

- Severe pulmonary hypertension

- Within the past 6 months:

-- Acute pulmonary embolus

-- Deep vein thrombosis

- Within the past month:

-- Heart attack

-- Unstable or stable angina (cardiac chest pain)

-- Left main coronary artery disease

-- Symptomatic heart failure

-- Uncontrolled hypertension (SBP > 180 mm Hg or DBP > 100mm Hg)

-- Severe valvular heart disease

-- Uncontrolled metabolic disease (diabetes with fasting BS >300 mg/dl, thyrotoxicosis, myxedema)

-- Aortic aneurism (>45 mm diameter) or aortic dissection

-- Uncontrolled slow or fast heart rhythm causing symptoms or hemodynamic compromise

-- Hypertrophic obstructive cardiomyopathy

Exclusion Criteria for Women Free of Cancer for Comparison:

- Inflammatory conditions such as lupus or inflammatory bowel disease

- Overt coronary artery disease or heart failure

- Those with ferromagnetic cerebral aneurysm clips or other intracranial metal; pacemakers, defibrillators, functioning neurostimulator devices or other implanted non-compatible MRI devices

- Symptomatic claustrophobia

- At the beginning of the study, pregnant women or women who are breast feeding will not be enrolled.

- Severe pulmonary hypertension

- Within the past 6 months:

-- Acute pulmonary embolus

-- Deep vein thrombosis

- Within the past month:

-- Heart attack

-- Unstable or stable angina (cardiac chest pain)

-- Left main coronary artery disease

-- Symptomatic heart failure

-- Uncontrolled hypertension (SBP > 180 mm Hg or DBP > 100mm Hg)

-- Severe valvular heart disease

-- Uncontrolled metabolic disease (diabetes with fasting BS >300 mg/dl, thyrotoxicosis, myxedema)

-- Aortic aneurism (>45 mm diameter) or aortic dissection

-- Uncontrolled slow or fast heart rhythm causing symptoms or hemodynamic compromise

-- Hypertrophic obstructive cardiomyopathy

Updated on 04 Aug 2024. Study ID: 1902716312 (WF-97415)

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Zip Code
Please provide your 5-digit zip code
0 0 /250
Other language

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team